Bovine herpesvirus 4 based vector as a potential oncolytic-virus for treatment of glioma

Virology Journal

Volumn 7, Issue , 2010, Pages

  Redaelli, Marco ^a   Mucignat Caretta, Carla ^a   Cavaggioni, Andrea ^a   Caretta, Antonio ^b   D'Avella, Domenico ^a   Denaro, Luca ^a   Cavirani, Sandro ^b   Donofrio, Gaetano ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; ONCOLYTIC VIRUS; VIRUS VECTOR;

AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BOVINE HERPESVIRUS 4; CANCER GROWTH; CONTROLLED STUDY; GENE TARGETING; GENE THERAPY; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; RAT; TREATMENT RESPONSE; TUMOR VOLUME; VIRUS EXPRESSION; ANIMAL; BRAIN; CELL CULTURE; GENE VECTOR; GENETICS; PATHOGENICITY; VIROLOGY; VIRULENCE;

BOVINE HERPESVIRUS 4; RATTUS; RODENTIA;

ANIMALS; BRAIN; CELLS, CULTURED; GENETIC VECTORS; GLIOMA; HERPESVIRUS 4, BOVINE; HUMANS; MICE; ONCOLYTIC VIRUSES; RATS; VIRULENCE;

EID: 78049321960     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-298     Document Type: Article

References (11)

1. Gene therapy for malignant glioma: current clinical status. KJ Pulkkanen S Yla-Herttuala, Mol Ther 2005 12 4 585 598 10.1016/j.ymthe.2005.07.357 16095972
2. Genome sequence of bovine herpesvirus 4, a bovine Rhadinovirus, and identification of an origin of DNA replication. W Zimmermann H Broll B Ehlers HJ Buhk A Rosenthal M Goltz, Journal of virology 2001 75 3 1186 1194 10.1128/JVI.75.3.1186-1194.2001 11152491
3. Potential of bovine herpesvirus 4 as a gene delivery vector. G Donofrio S Cavirani T Simone VL van Santen, J Virol Methods 2002 101 1-2 49 61 10.1016/S0166-0934(01)00419-0 11849683
4. Bovine herpesvirus type 4: a special herpesvirus (review article). L Egyed, Acta veterinaria Hungarica 2000 48 4 501 513 11402667
5. Investigation of the susceptibility of human cell lines to bovine herpesvirus 4 infection: demonstration that human cells can support a nonpermissive persistent infection which protects them against tumor necrosis factor alpha-induced apoptosis. L Gillet F Minner B Detry F Farnir L Willems M Lambot E Thiry PP Pastoret F Schynts A Vanderplasschen, Journal of virology 2004 78 5 2336 2347 10.1128/JVI.78.5.2336-2347.2004 14963130
6. Bovine herpesvirus 4 induces apoptosis of human carcinoma cell lines in vitro and in vivo. L Gillet B Dewals F Farnir L de Leval A Vanderplasschen, Cancer research 2005 65 20 9463 9472 10.1158/0008-5472.CAN-05-1076 16230410
7. Characterization of a bovine herpesvirus type 4 isolated from the spinal cord of a cow with astasia. Y Yamamoto K Murakami Y Inoshima T Nakane K Saika H Sentsui, Archives of virology 2000 145 11 2363 2370 10.1007/s007050070026 11205123
8. Transduction of the rat brain by Bovine Herpesvirus 4. M Redaelli A Cavaggioni C Mucignat-Caretta S Cavirani A Caretta G Donofrio, Genet Vaccines Ther 2008 6 6 10.1186/1479-0556-6-6 18267037
9. Stable cell membrane labelling. PK Horan SE Slezak, Nature 1989 340 6229 167 168 10.1038/340167a0 2662017
10. Herpesvirus saimiri as a model for gammaherpesvirus oncogenesis. JU Jung JK Choi A Ensser B Biesinger, Seminars in cancer biology 1999 9 3 231 239 10.1006/scbi.1998.0115 10343074
11. Combined HSV-TK/IL-2 gene therapy in patients with recurrent glioblastoma multiforme: biological and clinical results. F Colombo L Barzon E Franchin M Pacenti V Pinna D Danieli M Zanusso G Palu, Cancer gene therapy 2005 12 10 835 848 10.1038/sj.cgt.7700851 15891772